Heart Failure Clinical Trials in Herlev
6 recruitingHerlev, Denmark
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled641 locationsNCT06935370
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled564 locationsNCT07037459
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
Not Applicable
Integrated Approach in Frail Older People with Atrial Fibrillation
Heart FailureDiabetes MellitusHypertension+7 more
Heart Care Foundation1,250 enrolled50 locationsNCT06775028
Recruiting
Phase 3
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Heart FailureCardiovascular DiseasesType 1 Diabetes+1 more
Steno Diabetes Center Copenhagen2,000 enrolled2 locationsNCT06082063
Recruiting
Phase 4
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Heart FailureChronic Kidney DiseasesDiabetes Mellitus, Type 2
Herlev and Gentofte Hospital17,200 enrolled12 locationsNCT06642272